Clinical trial for Intermittent Claudication
Official title Supervised Exercise-based Rehabilitation for People With Intermittent Claudication in Denmark
ClinicalTrials.gov ID: NCT06299956
What this study is testing
- What it's testing
- The study will describe how to set up and run a supervised exercise program, track its delivery and quality, and collect data on its benefits and harms.
- Who it's for
- Adults in Denmark who have intermittent claudication and can walk on a treadmill.
- What's involved
- Participants will walk on a treadmill three times a week for 12 weeks and, if they smoke, will receive smoking‑cessation support.
- Time commitment
- The program lasts 12 weeks of exercise, with follow‑up visits up to 6 months after the program ends.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Relevant symptoms of intermittent claudication; leg pain when walking due to arteriosclerosis and relieve of symptoms during rest.
- Distal blood pressure with an ankle-brachial index (ABI) \> 50 mmHg for non-diabetics or toe brachial index (TBI) \> 40 mmHg for diabetics.
You likely can't join if
- Evaluated by a vascular surgeon: patients with contraindications e.g.
The study team makes the final eligibility decision.
Where it is enrolling
- Slagelse, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Slagelse, Denmark. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.